Kathryn Cashman Rogers

Kathryn Cashman Rogers is an innovation strategist, biomedical engineer, and patented medical device inventor with a deep background in life sciences, venture strategy, and health technology.

She has been instrumental in raising over $100 million in early-stage capital across the startup and life sciences ecosystem. Her own patented technology—a novel system for inhalant delivery and breath analysis—is valued at $10 million at the pre-seed stage and reflects her ability to translate complex innovations into scalable, market-ready solutions.

Kathryn’s work spans product development, regulatory strategy, and commercialization, with a focus on breakthrough science at the intersection of biotechnology, AI, and life sciences. She combines innovation, engineering precision, operational insight, and long-term vision to support ventures advancing impactful, future-forward solutions.

She currently splits her time between Dallas and Nashville with her husband, Chris, and is committed to shaping the future of health and innovation through thoughtful, purpose-driven collaboration.